Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment

RTTNews | 1127 days ago
Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment

(RTTNews) - Biopharmaceutical company Lipocine Inc. (LPCN) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a potential treatment for adults with epilepsy.

Lipocine plans to initiate a Phase 2 photosensitive epilepsy (PSE) study to evaluate the safety, tolerability, and efficacy of oral LPCN 2101.

LPCN 2101 is an orally delivered, endogenous neuroactive steroid (NAS), a positive allosteric modulator (PAM) of GABAA receptor, with potential therapeutic effects in neurological and mood disorders.

For More Such Health News, visit rttnews.com

read more
Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Canadian stocks may open with a slightly positive bias on Monday with investors looking ahead to the crucial U.S. inflation data due this week. The focus is also Trump administration's trade negotiations with China, and on the upcoming talks between the U.S. and Russia, aimed at bringing an end to the war in Ukraine.
RTTNews | 1h 37min ago
FTSE 100 Up Marginally As Investors Look For Direction

FTSE 100 Up Marginally As Investors Look For Direction

The U.K. market is up in positive territory a little before noon on Monday with select counters attracting some strong buying interest. Uncertainty on the tariff front is rendering the mood a bit cautious and limiting the market's upside.
RTTNews | 3h 13min ago
CAC 40 Drifts Lower In Lackluster Trade

CAC 40 Drifts Lower In Lackluster Trade

French stocks are down in negative territory on Monday as investors look for direction and make cautious moves while awaiting U.S. - Russia talks set to take place later in the week.
RTTNews | 3h 33min ago
UK Job Placements Decline Sharply On Weaker Confidence & Budget Pressures

UK Job Placements Decline Sharply On Weaker Confidence & Budget Pressures

UK job placements logged a steep decline in July due to weaker confidence around the economic outlook and rising employment costs, monthly data from S&P Global showed Monday. Permanent staff appointments declined sharply in July and temp billings registered its biggest fall in five months, the KPMG/REC Report on Jobs said.
RTTNews | 4h 32min ago